Mechanism of Action
Glucagon-like Peptide-1 (GLP-1) Agonists
GLP-1 Receptor Agonist
Clinical Trials (5)
Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)
A Research Study Looking at Blood Sugar Control in People With Type 2 Diabetes Previously Treated With Premix Insulin and Initiating Treatment With Insulin Degludec/Liraglutide (IDegLira) in Local Clinical Practice in Croatia
Efficacy of Liraglutide Therapy in Patients With IPAA
Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity
A Study in Men With Overweight to Test How Well Different Doses of BI 1820237 Are Tolerated When Given as an Injection Alone or in Combination With Liraglutide
Loss of Exclusivity
Patent Records (4)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 8114833 | Aug 13, 2025Expired | SubstanceProduct | — |
| 8114833*PED | Feb 13, 2026Expired | — | |
| 9968659 | Jan 9, 2037 | U-2313 | |
| 9968659*PED | Jul 9, 2037 | — |